MedPath

Implementation of a Combination Intervention for Sustainable Blood Pressure Control

Not Applicable
Active, not recruiting
Conditions
Hypertension
Registration Number
NCT05492955
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

This is a randomized clinical trial intended to identify the optimal strategy of blood pressure management in rural South Africa using Community Health Workers (CHWs) in conjunction with in-home BP monitoring among adults.

Detailed Description

We will conduct a trial using CHWs in conjunction with in-home BP monitoring among 774 adults ≥ 18 years old residing in uMkhanyakude District in northern KwaZulu-Natal in an area that is served by a CHW. Eligible participants will be recruited from prior community-based hypertension screening programs, CHW-led hypertension screening activities, and/or from trial clinics where they are accessing care. Consenting participants will be randomized to one of the three study arms of hypertension care (258 participants per arm): 1) clinic-based standard of care model (SOC); 2) community health worker-based blood pressure monitoring model (CHW); 3) and enhanced community health worker-based model, including mobile health blood pressure monitoring model (eCHW+). Independent of clinical care, all participants will be seen at enrollment and at 6 months for BP monitoring and data collection by study nurses for outcome assessments. The primary effectiveness outcome will be assessed in an intention-to-treat analysis and defined as the change in systolic blood pressure (SBP) 6 months after enrollment. The secondary effectiveness outcome will be the proportion of participants with controlled blood pressure, as defined by an SBP \<140 mmHg and a diastolic BP (DBP) \<90 mmHg 6 months after enrollment.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
774
Inclusion Criteria
  • Age greater than 18 years old
  • Residing in uMkhanyakude District in northern KwaZulu-Natal in an area that is served by a CHW.
  • Elevated blood pressure (blood pressure > 140/90 mmHg) on two measurements.
Exclusion Criteria
  • Pregnant or breast-feeding women.
  • Severe, symptomatic hypertension with a measured blood pressure > 180/110 mmHg.
  • Known, advanced chronic kidney disease. GFR < 60 ml/min/1.73 m2.
  • Current use of at least 3 different anti-hypertensive therapies at full dose.
  • Planning to move within the next 24 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mean systolic blood pressure change6 months

Absolute change in systolic blood pressure (SBP) between baseline and 6 months after enrollment.

Secondary Outcome Measures
NameTimeMethod
Achievement of blood pressure control6 months

Blood pressure control, defined as a BP \<140/90 6 months after enrollment

Trial Locations

Locations (1)

Africa Health Research Institute (AHRI)

🇿🇦

Mtubatuba, KwaZulu-Natal, South Africa

Africa Health Research Institute (AHRI)
🇿🇦Mtubatuba, KwaZulu-Natal, South Africa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.